<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02085876</url>
  </required_header>
  <id_info>
    <org_study_id>HAMZA APJ 2013</org_study_id>
    <nct_id>NCT02085876</nct_id>
  </id_info>
  <brief_title>Quantitative and Qualitative MRI Study of Steatosis in Patients With Metabolic Steatopathy</brief_title>
  <acronym>IRM St√©atose</acronym>
  <official_title>Quantitative and Qualitative MRI Study of Steatosis in Patients With Metabolic Steatopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      This is a single centre prospective open-label, non-randomised pilot study whose aim is to
      identify MRI parameters to better evaluate inflammation and liver fibrosis and thus, in the
      near future, to avoid the need for liver biopsy.

      To achieve this:

        -  The MRI study will be completed by adding two sequences: Measurement of T1 and multiecho
           T2*. The other data will be extracted from usual sequences.

        -  Part of the histological samples will be used for the weighted levels of fat and iron,
           and for the lipidomic study.

        -  Usual blood samples will be completed by samples for the serum library
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To determine a correlation coefficient &gt; 0.80, alpha 0.05 and beta 0.20 between the MRI markers relevant.</measure>
    <time_frame>Baselines</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine the correlation between the unsaturated fat measurements and MRI Lipidomics Spectro analysis.</measure>
    <time_frame>Baselines</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Overweight</condition>
  <condition>Type 2 Diabetes</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Patients requiring a liver biopsy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>2 additional MRI sequences</intervention_name>
    <arm_group_label>Patients requiring a liver biopsy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>An additional blood sample</intervention_name>
    <arm_group_label>Patients requiring a liver biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Overweight patients or patients with type 2 diabetes or obese patients (who present a liver
        anomaly and should undergo bariatric surgery)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have been informed about the research

          -  Patients with national health insurance cover

          -  Patients who are overweight (BMI &gt; 25) or have type 2 diabetes suggesting a
             disturbance of hepatic enzymes (ASAT &lt; 8 times normal values and ALAT &gt; twice normal
             values) after a complete hepatopathy assessment

          -  Obese patients with a hepatic anomaly (steatosis) revealed by imaging or biological
             assessment (ASAT &lt; 8 times normal values and ALAT &gt; twice normal values) who are
             eligible for bariatric surgery and a preoperative liver MRI examination.

        Exclusion Criteria:

          -  Non-corrected coagulation disorder.

          -  Patients aged over 80 years

          -  Patients aged less than 18 years

          -  Patients without legal protection

          -  Patients with a contra-indication for MRI (Pacemaker, intraocular metallic foreign
             body, weight&gt;150kg)

          -  Patients without national health insurance cover
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Samia HAMZA</last_name>
    <phone>3 80 29 37 50</phone>
    <phone_ext>+33</phone_ext>
    <email>samia.hamza@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de DIJON</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Samia HAMZA</last_name>
      <phone>3 80 29 37 50</phone>
      <phone_ext>+33</phone_ext>
      <email>samia.hamza@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2014</study_first_submitted>
  <study_first_submitted_qc>March 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2014</study_first_posted>
  <last_update_submitted>March 12, 2014</last_update_submitted>
  <last_update_submitted_qc>March 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>patients</keyword>
  <keyword>present</keyword>
  <keyword>undergo bariatric surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

